Stock RDNT RADNET, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials RadNet, Inc.

Equities

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
65.16 USD +3.94% Intraday chart for RadNet, Inc. +14.94% +87.40%
Jul. 15 Truist Securities Adjusts Price Target on RadNet to $70 From $63, Maintains Buy Rating MT
Jul. 11 Jefferies Adjusts Price Target on RadNet to $75 From $61, Maintains Buy Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,021 1,011 1,609 1,080 2,361 4,632 - -
Enterprise Value (EV) 1 1,021 1,011 1,609 1,080 2,361 4,838 4,729 4,632
P/E ratio 70 x -67.5 x 65.5 x 111 x 695 x 99 x 66.5 x 68.9 x
Yield - - - - - - - -
Capitalization / Revenue 0.88 x 0.94 x 1.22 x 0.76 x 1.46 x 2.67 x 2.45 x 2.3 x
EV / Revenue 0.88 x 0.94 x 1.22 x 0.76 x 1.46 x 2.79 x 2.5 x 2.3 x
EV / EBITDA 6.22 x 7.25 x 7.35 x 5.61 x 10.2 x 17.6 x 15.5 x 14.3 x
EV / FCF 33.8 x 7.24 x 139 x 40.1 x 53.3 x 79.5 x 52.6 x 54 x
FCF Yield 2.96% 13.8% 0.72% 2.5% 1.87% 1.26% 1.9% 1.85%
Price to Book 6.73 x 6.1 x 7.04 x 3.26 x - 3.91 x 3.52 x -
Nbr of stocks (in thousands) 50,272 51,636 53,437 57,361 67,895 73,880 - -
Reference price 2 20.30 19.57 30.11 18.83 34.77 62.69 62.69 62.69
Announcement Date 3/12/20 3/8/21 3/1/22 3/1/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,154 1,072 1,315 1,430 1,617 1,733 1,890 2,010
EBITDA 1 164.1 139.5 218.9 192.5 232.3 274.7 304.5 325
EBIT 1 69.88 35.68 82.55 46.36 98.7 118.5 137.6 153.2
Operating Margin 6.05% 3.33% 6.28% 3.24% 6.11% 6.84% 7.28% 7.62%
Earnings before Tax (EBT) 1 29.67 -0.854 58.88 42.97 38.81 84.95 111.9 126.5
Net income 1 14.76 -14.84 24.73 10.65 3.044 37.85 57.51 67.63
Net margin 1.28% -1.38% 1.88% 0.74% 0.19% 2.18% 3.04% 3.37%
EPS 2 0.2900 -0.2900 0.4600 0.1700 0.0500 0.6333 0.9433 0.9100
Free Cash Flow 1 30.17 139.6 11.62 26.97 44.26 60.86 89.91 85.7
FCF margin 2.61% 13.02% 0.88% 1.89% 2.74% 3.51% 4.76% 4.26%
FCF Conversion (EBITDA) 18.38% 100.09% 5.31% 14.01% 19.05% 22.16% 29.52% 26.37%
FCF Conversion (Net income) 204.45% - 46.98% 253.2% 1,454.11% 160.81% 156.34% 126.72%
Dividend per Share - - - - - - - -
Announcement Date 3/12/20 3/8/21 3/1/22 3/1/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 333.2 341.8 354.4 350 383.9 390.6 403.7 402 420.4 431.7 438.5 429.6 456.7 461.7 473.3
EBITDA 1 54.51 38.13 51.34 45.77 57.23 48.16 60.44 57.92 65.81 58.46 68.83 69.22 78.31 66.3 74.87
EBIT 1 4.652 -1.719 19.56 6.924 21.6 6.671 24.44 43.25 24.34 11.34 33.11 33.54 39.14 17.96 33.82
Operating Margin 1.4% -0.5% 5.52% 1.98% 5.63% 1.71% 6.05% 10.76% 5.79% 2.63% 7.55% 7.81% 8.57% 3.89% 7.14%
Earnings before Tax (EBT) 1 3.34 9.859 17.23 8.635 7.243 -13.15 13.94 31.29 6.73 3.546 24.71 25.49 30.89 11.58 27.61
Net income 1 -3.823 3.013 7.905 0.668 -0.934 -21 8.369 17.54 -1.858 -2.779 11.79 12.56 16.28 1.846 14.13
Net margin -1.15% 0.88% 2.23% 0.19% -0.24% -5.38% 2.07% 4.36% -0.44% -0.64% 2.69% 2.92% 3.56% 0.4% 2.98%
EPS 2 -0.0700 0.0500 0.1300 0.0100 -0.0200 -0.3600 0.1200 0.2500 -0.0300 -0.0400 0.1600 0.1700 0.2200 0.0250 0.1900
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/1/22 5/9/22 8/9/22 11/9/22 3/1/23 5/9/23 8/8/23 11/8/23 2/29/24 5/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 206 97 -
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - - 0.751 x 0.3185 x -
Free Cash Flow 1 30.2 140 11.6 27 44.3 60.9 89.9 85.7
ROE (net income / shareholders' equity) 10.6% - 12.5% 4.28% 7.01% 3.6% 5.5% 6.1%
ROA (Net income/ Total Assets) 1.07% - 1.29% 0.54% 1.32% 1.3% 2.1% 2.5%
Assets 1 1,377 - 1,923 1,989 230.9 2,911 2,739 2,705
Book Value Per Share 2 3.010 3.210 4.270 5.770 - 16.10 17.80 -
Cash Flow per Share - - - - - - - -
Capex 1 73 93.3 138 119 177 147 156 160
Capex / Sales 6.32% 8.71% 10.48% 8.35% 10.92% 8.47% 8.26% 7.96%
Announcement Date 3/12/20 3/8/21 3/1/22 3/1/23 2/29/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for RadNet, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
62.69 USD
Average target price
64.5 USD
Spread / Average Target
+2.89%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
RADNET, INC. Stock RadNet, Inc.
+86.02% 4.63B
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-18.17% 8.55B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+16.31% 2.98B
SYNLAB AG Stock SYNLAB AG
-3.15% 2.65B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-5.07% 1.89B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-53.27% 1.81B
FLEURY S.A. Stock Fleury S.A.
-13.19% 1.56B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+23.57% 1.27B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-47.38% 1.07B
OPKO HEALTH, INC. Stock OPKO Health, Inc.
-4.97% 997M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. RDNT Stock
  4. Financials RadNet, Inc.